Clinical Trials on Coagulation Disorders in Mexico

Total 2584 results

Novo Nordisk A/S

Completed

Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients

Congenital Bleeding Disorder | Haemophilia A

Mexico
Hospital Regional de Alta especialidad de Ixtapaluca

Unknown

Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection

Pneumonia | Covid19 | Coagulation Disorder | Pulmonary Embolism

Mexico
Bayer

Completed

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America

Hemophilia A | Blood Coagulation Disorders

Mexico, Venezuela
CSL Behring
Parexel

Completed

Study of Biostate® in Children With Hemophilia A

Hemophilia A

Ukraine, Lebanon, Belarus, Georgia, Guatemala, Mexico
El Instituto Nacional de Neurologia y Neurocirugia...
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico

Recruiting

TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic

Major Depressive Disorder

Mexico
Fondazione Angelo Bianchi Bonomi
Sintesi Research Srl

Completed

Survey of Inhibitors in Plasma-Product Exposed Toddlers (SIPPET)

Hemophilia A

United States, India, Spain, Argentina, Austria, Brazil, Chile, Egypt, Iran, Islamic Republic of, Italy, Mexico, Saudi Arabia, South Africa, Turkey
Angel Augusto Perez Calatayud
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

Patient Blood Management for Massive Obstetric Hemorrhage

Post Partum Hemorrhage | Transfusion Related Complication | Fibrinogenolysis; Hemorrhage | Fibrinogen; Deficiency, Acquired | Massive Hemorrhage

Mexico
Laboratoire français de Fractionnement et de Biotechnologies
LFB USA, Inc.

Completed

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures (PerSept3)

Hemophilia

United States, Ukraine, Mexico, Russian Federation, South Africa, Spain
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT (DA-VINCI)

Cognitive Impairment | Hemodialysis Complication | Cerebral Edema | Dialysis; Complications

Mexico
Universidad Westhill, Facultad de Psicología

Completed

Anxiety, Depression and Substance Use in Undergraduate Health Science Students During the Covid-19 Pandemic.

Substance-Related Disorders | Depression | Anxiety

Mexico
Coordinación de Investigación en Salud, Mexico
Hospital Infantil de Mexico Federico Gomez

Unknown

Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019 (ECIRCCOS)

Insulin Resistance | Obesity, Childhood | Insulin Sensitivity

Mexico
Instituto Nacional de Psiquiatría Dr. Ramón de...

Completed

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Second Generation Antipsychotic Induced Metabolic Adverse Effects

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Active, not recruiting

Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota

Obesity | Pre Diabetes

Mexico
Universidad Autonoma de San Luis Potosí

Completed

Factors Associated With Dermatoporosis (FAWD)

Senile Purpura

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Efficacy and Safety of the Implementation of an Algorithm for Enteral Nutrition Support.

Malnutrition

Mexico
Catalyst Biosciences

Terminated

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

Hemophilia A With Inhibitor | Hemophilia B With Inhibitor

United States, United Kingdom, Taiwan, Italy, Spain, India, Turkey, Malaysia, Russian Federation, Armenia, Georgia, Hungary, Mexico, Poland, South Africa, Ukraine
Boston Medical Group

Recruiting

Effectiveness and Safety of TENS Therapy for Premature Ejaculation (TENSPE2)

Premature Ejaculation | TEN | Sex Disorder

Mexico
Novo Nordisk A/S

Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

United States
Centro Interdisciplinario de Ciencias de la Salud...

Completed

Effect of Cognitive Behavioral Therapy and Phototherapy on Glycosylated Hemoglobin, CLOCK Genes and Quality of Life in Patients With Type 2 Diabetes Mellitus and Insomnia

Type 2 Diabetes

Mexico
Pfizer

Completed

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Hemophilia B

Canada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors (STASEY)

Hemophilia A

Canada, Australia, Belgium, India, Germany, Israel, Italy, Spain, Colombia, United Kingdom, Netherlands, Saudi Arabia, Hungary, Guatemala, Russian Federation, Poland, Switzerland, Finland, Panama, Brazil, Mexico, Portugal, Romania, Sw...
Universidad Nacional Autonoma de Mexico

Completed

Healthcare Intervention Program on Treatment Adherence in People With Newly Diagnosed Type 2 Diabetes Mellitus.

Quality of Life | Treatment Adherence | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Mexico
Laboratoire français de Fractionnement et de Biotechnologies

Recruiting

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM (SCOPE HIM)

Hemophilia

United States, Thailand, Mexico, Turkey, South Africa, Malaysia
Universidad Westhill, Facultad de Psicología

Completed

Mental Health in Latin American Countries With Different Economic Incomes During the Covid-19 Pandemic.

Substance-Related Disorders | Depression | Anxiety

Mexico
St. Joseph's Healthcare Hamilton
McMaster University

Completed

Oral Vitamin K for Warfarin Associated Coagulopathy

Thrombosis | Bleeding | Coagulation

Canada, Singapore, United States, Italy
Genzyme, a Sanofi Company

Completed

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis (ATLAS-PPX)

Hemophilia

United States, Australia, China, Denmark, France, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Mexico
Grupo Cooperativo de Hemopatías Malignas

Withdrawn

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Multiple Myeloma

Mexico
Instituto Mexicano del Seguro Social

Completed

Radiotherapy in Primary Mediastinal Lymphoma (pml)

Adjuvant Radiotherapy on Complete Remission Patients

Mexico
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A (guardian™ 5)

Congenital Bleeding Disorder | Haemophilia A

Italy, Sweden, Netherlands, Austria, Spain, United States, Switzerland, Germany, France, Hungary, Greece, Slovenia, Czechia, Slovakia, Poland
Laboratorios Silanes S.A. de C.V.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Efficacy Study of Metformin Glycinate on Postprandial Lipemia

Type 2 Diabetes

Mexico
Hospital Universitario Dr. Jose E. Gonzalez

Unknown

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Immune Thrombocytopenia

Mexico
Pfizer

Completed

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Hemophilia A

United States, Argentina, Austria, Colombia, Croatia, Jordan, Mexico, New Zealand, Oman, Peru, Poland, Romania, Turkey
Hospital Civil de Guadalajara

Completed

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Primary Immune Thrombocytopenia

Mexico
Baxalta now part of Shire
Baxter BioScience

Completed

ADVATE Post Authorization Safety Surveillance

Hemophilia A

United States
Octapharma

Recruiting

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients (Protect-NOW)

Haemophilia A

Belgium, Italy, United States, Azerbaijan, Belarus, Canada, Estonia, France, Germany, Hungary, Lithuania, Russian Federation, Spain, Turkey, United Kingdom, Mexico
Universidad Nacional Autonoma de Mexico
Hospital Infantil de Mexico Federico Gomez; Centro de Investigación y Estudios...

Unknown

Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia

Febrile Neutropenia

Mexico
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT

Immune Thrombocytopenic Purpura

Mexico
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP

Immune Thrombocytopenic Purpura

Mexico
Centro Universitario de Ciencias de la Salud, Mexico

Completed

Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome

Metabolic Syndrome

Mexico
Instituto Nacional de Psiquiatría Dr. Ramón de...

Completed

Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts. (MADC)

Drug-withdrawal. | Drug Abuse | Drug-induced Depressive State | AOD Craving | AODR Depressive State

Mexico
New York Presbyterian Hospital
Manchester University NHS Foundation Trust

Terminated

International Immune Tolerance Study

Hemophilia A With Inhibitors

United States
Centro Universitario de Ciencias de la Salud, Mexico

Completed

Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome

Metabolic Syndrome

Mexico
Bayer

Completed

BAY81-8973 Pediatric Safety and Efficacy Trial

Haemophilia A

Spain, Russian Federation, United States, Hungary, Italy, Mexico, Norway, Romania, Bulgaria, Canada, Argentina, Denmark, Israel, Poland, Ireland, Latvia, Lithuania
Bayer

Completed

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A (Leopold II)

Hemophilia A

China, United States, Ukraine, Taiwan, Mexico, Thailand, Romania, Colombia, Turkey, Serbia, Russian Federation, South Africa, Japan, Indonesia, Argentina, Czech Republic, India, Slovakia
Bioverativ, a Sanofi company

Completed

A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A (XTEND-1)

Factor VIII Deficiency

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
David Gomez Almaguer

Unknown

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Thrombotic Thrombocytopenic Purpura | Immune Thrombocytopenia

Mexico
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Idiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, Autoimmune

Mexico
Instituto Nacional de Rehabilitacion

Not yet recruiting

BCI-FES for Upper Limb Rehabilitation in Chronic Stroke (BCI-FES)

Stroke | Upper Extremity Paresis | Neuronal Plasticity

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Glucose Intolerance | Cardiovascular Risk Factor | Postprandial Hyperglycemia

Mexico
Grupo Cooperativo de Hemopatías Malignas

Completed

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)

Mexico

Clinical Trials on Coagulation Disorders in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations